By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Opko Health, Inc. 

Miami  Florida    U.S.A.
Phone: n/a Fax: n/a



Company News
Opko Health, Inc. Licensee Tesaro, Inc. (TSRO) Submits New Drug Application for Rolapitant 9/8/2014 12:28:41 PM
Opko Health, Inc. Release: Rayaldee Phase 3 Trial Meets Primary Endpoints 8/12/2014 9:30:11 AM
Opko Health, Inc. Announces Second Quarter Operating And Financial Results 8/12/2014 8:36:37 AM
Opko Health, Inc. To Announce Top Line RAYALDEE Results And Second Quarter 2014 Financial Results On August 11, 2014 8/7/2014 10:29:35 AM
Opko Health, Inc. Granted Patent From U.S. Patent & Trademark Office For RAYALDEE 7/22/2014 10:06:07 AM
Opko Health, Inc.'s Long-Acting Clotting Factor VIIa-CTP Receives Positive Opinion For Three Orphan Drug Designations In Europe 7/9/2014 11:33:50 AM
Opko Health, Inc. Granted Patent from European Patent Office For Lagova™ 6/27/2014 10:22:05 AM
Opko Health, Inc. Release: Strong Data from Lagova™ Phase II Clinical Study Presented During Webcast 6/26/2014 10:55:32 AM
Opko Health, Inc. To Hold Conference Call To Discuss Six Month Data From Phase 2 hGH-CTP Trial 6/20/2014 10:49:20 AM
Opko Health, Inc. Completes Acquisition Of Inspiro Medical Ltd. 5/22/2014 9:44:24 AM